The economy grew 6.4% in the January-to-March period and seems to be further accelerating now, but it's not clear whether trends such as price increases, strong consumer spending and lagging employment are further signs of the recovery or indicators of problems. Some economists say weak job growth is a result of a short-term mismatch, where fewer applicants are able to respond to the surge in job openings because of pandemic-related home issues, and a jump in spending might have been a temporary response to relief payments rather than higher consumer confidence.
Venture capital funding for companies in the infectious disease space hit a historic high last year, according to a Pitchbook analysis. Venture capital investor Andrew Nerlinger says a new market is emerging, driven by a new understanding of infectious diseases, but he does predict some contraction.
Moderna announced it is seeking FDA authorization for use of its COVID-19 vaccine among young people ages 12 to 17. The COVID-19 vaccine by Pfizer and German partner BioNTech has already been authorized for use among patients ages 12 to 17, and more than 7 million Americans in that age group have received at least one dose.
Many older adults take multiple prescriptions to manage chronic conditions and maintain overall health, with some taking up to 14 medications at once from various doctors and specialists. The Society for Post-Acute and Long-Term Care Medicine, or AMDA, has initiated a campaign -- "Drive to Deprescribe" -- with a goal of reducing polypharmacy by 25% within one year, and three pharmacies and 2,000 facilities have enrolled.
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.
Contact PCMA Charles Cote
Vice President, Strategic Communications